Showing results (201-210 of 588) with videos related to

Sort By:
Pageof 59
European Journal of Human Genetics : EJHG|May 23, 2013
Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephalyJudith A Hobert, Rebecca Embacher, Jessica L Mester, et al.
The Lancet. Diabetes & Endocrinology|November 29, 2020
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literatureIrina Bancos, Elizabeth Atkinson, Charis Eng, et al.
Annales D'Endocrinologie|December 29, 2020
The risks of medical treatment of prolactinomaFrederic Castinetti, Frederique Albarel, Vincent Amodru, et al.
Molecular Autism|February 5, 2016
Erratum to: Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traitsXin He, Stetson Thacker, Todd Romigh, et al.
Endocrine-Related Cancer|February 19, 2025
Divergent PTEN-p53 interaction upon DNA damage in a human thyroid organoid model with germline PTEN mutationsJuan Andres Venegas, Omer Enes Onur, Shin Chung Kang, et al.
Human Molecular Genetics|February 7, 2017
Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cellsWanfeng Yu, Ying Ni, Motoyasu Saji, et al.
Plos One|March 8, 2013
cgaTOH: extended approach for identifying tracts of homozygosityLi Zhang, Mohammed S Orloff, Sean Reber, et al.
Nature Clinical Practice. Oncology|September 28, 2007
Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paragangliomaKevin M Zbuk, Attila Patocs, Amy Shealy, et al.
Molecular Autism|November 19, 2015
Cytoplasm-predominant Pten associates with increased region-specific brain tyrosine hydroxylase and dopamine D2 receptors in mouse model with autistic traitsXin He, Stetson Thacker, Todd Romigh, et al.
Scientific Reports|January 8, 2024
Characterization of immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancersChin-Chih Liu, Matthew Wolf, Ruth Ortego, et al.
Pageof 59